Product Code: BIO117A
Abstract
REPORT HIGHLIGHTS
This report provides:
An overview of the global market for cell and tissue analysis products,
including commercialized products used in the isolation, purification, and
analysis of cells, as well as novel products and technologies that may be
commercially viable in the next few years; this report focuses on cell and
tissue separation
Analyses of global market trends, with data from 2011, estimates for 2012, and
projections of compound annual growth rates (CAGRs) through 2017
Detailed discussion of biospecimens, enzymatic and mechanical tissue
dissociation products, flow cytometry hardware and software, magnetic cell
separation products, laser microdissection (LMD) systems, research antibodies,
cell-based assays, and products used in high-content screening (HCS) platforms
Profiles of large and established producers in cell and tissue analysis
product market segments, as well as numerous smaller specialized market players
Market segmentation within the areas of biospecimen vendors, cell separation
products, and cell and tissue analysis products
Examination of each technology by application type and in the context of
relevant technological and regulatory forces to determine its current market
status and projected growth.
REPORT SCOPE
INTRODUCTION
STUDY OBJECTIVES
BCC's goal in conducting this study is to provide an overview of the current
and future characteristics of the global market for cell and tissue analysis
products. The key objective is to present a comprehensive analysis of the
future direction of cell and tissue products that will serve as a valuable
tool for their use of.
This report explores present and future strategies within the cell and tissue
analysis market, including biospecimen-preparing techniques, cell and tissue
separation, and cell and tissue characterization products. The market's
improvisation, setbacks and needs are also discussed. The classifications,
comparisons and usage of cell and tissue analysis products are also presented
in this report.
A detailed analysis of the cell and tissue analysis industry structure has
been conducted. Revenues are broken down by region, and sales figures are
estimated for the five-year period from 2012 through 2017.
Applications for cell and tissue analysis products are discussed separately.
The report also covers significant patents and their allotments in each
category.
REASONS FOR DOING THIS STUDY
Extensive research in the field of cell and tissue analysis products has
revealed their specific functionality in providing specific analysis for the
healthcare and the biopharmaceutical industries. Modern industries have begun
to explore the advantages of cell and tissue analysis products in their
productions and processes, leading to the steady market in this area.
R&D spending, increasing competition, patent expiries and new technologies are
leading this market in a new direction. The new advancements, new product
launches and changing lifestyles have influenced the market to grow in the
foreseeable future. This study looks at many of the systems affected by these
factors.
Acquisition strategies and company collaborations are covered in this report.
This study also discusses the strength and weaknesses of each type of
technology in light of the new technologies, growing competition and changing
customer needs.
CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
This study contributes to the areas of market growth in cell and tissue
analysis manufacturers and users. It will be of interest to pharmaceutical
companies, biotechnical companies, research institutes and physicians.
SCOPE OF THE STUDY
The scope of this study encompasses cell and tissue analysis products in the
pharmaceutical and biotechnology markets. BCC analyzes each market and its
applications, regulatory environment, technology, market projection and market
share. Technological issues include the latest trends and developments. The
emerging markets for enzyme inhibitors include India, China, Japan, South
Korea, Taiwan, Canada, Africa, Australia and New Zealand.
METHODOLOGY
Both primary and secondary research methodologies were used in preparing this
study. BCC conducted a comprehensive literature search, which included
technical newsletters and journals, as well as many other sources. Data were
collected through interviews and correspondence with manufacturers of cell and
tissue analysis products technical experts. Projections were based on
estimates such as the current number of end users, potential end users,
mergers and acquisitions, and market trends.
INFORMATION SOURCES
Numerous companies were surveyed to obtain data for this study, including
manufacturers and end users of kinase inhibitors in therapeutic categories and
various disease sectors. Data were gathered from various industry sources.
BCC researchers spoke with officials within the industry and also consulted
newsletters; company literature; product literature; and a host of technical
articles, journals, indices and abstracts. Exhaustive investigations of
databases by key terminology were completed. In addition, data were compiled
from current financial, trade and government sources.
ABOUT THE AUTHOR
This study was carried out by a team of professionals in the biotechnology
industry. Shalini S. Dewan, the project manager, holds a Master's degree in
pharmaceutical chemistry and has more than 14 years of industry experience.
She has covered such research topics as compounds of potential pharmaceutical
interest from ibuprofen and 2-naphthyl acetic acid. Shalini was awarded a
Gold Medal by the Prime Minister of India for her work and has worked with top
companies in India and in the U.S. Her other reports with BCC include
Reagents for Chromatography; Spectroscopy: An Enduring Market; Advanced Drug
Delivery Systems: Technologies and Global Markets; Orthopedic Drugs, Implants
and Devices; Medical Imaging Reagents and Analysis Equipment; Pharmaceutical
Regulatory Industry; The Dynamic Media, Sera and Reagent Market in
Biotechnology; Contract Pharmaceutical Manufacturing, Research and Packaging:
Global Markets; Chiral Technology: Global Markets; Autacoids and Related
Drugs: Technologies and Global Markets; Contraceptives: Technologies and
Global Markets; Liver Disease Treatments: The Global Market; Hormone
Replacement Therapies and Other Hormone Therapies: Global Markets;
Cardiovascular Medicine: Diagnostics, Drugs and Devices; and Cancer Therapies:
Technologies and Global Markets.
Table of Contents
Chapter- 1: INTRODUCTION - Complimentary
- STUDY OBJECTIVES
- REASONS FOR DOING THIS STUDY
- CONTRIBUTIONS OF THE STUDY AND INTENDED AUDIENCE
- SCOPE OF THE STUDY
- METHODOLOGY
- INFORMATION SOURCES
- ABOUT THE AUTHOR
- RELATED BCC RESEARCH REPORTS
- BCC ONLINE SERVICES
- DISCLAIMER
Chapter- 2: SUMMARY
- Table Summary : GLOBAL CELL AND TISSUE ANALYSIS MARKET BY PRODUCT TYPE,
THROUGH 2017
- Figure Summary : GLOBAL CELL AND TISSUE ANALYSIS MARKET BY PRODUCT TYPE,
2010-2017
Chapter- 3: OVERVIEW
- INTRODUCTION
- CELLS
- CLASSIFICATION OF TECHNIQUES USED IN CELL AND TISSUE ANALYSIS
Chapter- 4: REGULATORY ISSUES
- CODE OF FEDERAL REGULATIONS
- DRUG APPROVALS
- RECALLS
Chapter- 5: NEW DEVELOPMENTS
- Table 10 : CELL AND TISSUE ANALYSIS PRODUCTS IN THE PIPELINE
- Table 11 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2012
- Table 12 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2011
- Table 13 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2010
Chapter- 6: GLOBAL MARKETS
- MARKETS BY TYPE
- BIOSPECIMEN-PREPARING TECHNIQUES
- CELL AND TISSUE SEPARATION PRODUCTS
- CELL AND TISSUE CHARACTERIZATION PRODUCTS
- BIOSPECIMEN-PREPARING TECHNIQUES
- CELL AND TISSUE SEPARATION PRODUCTS
- CELL AND TISSUE CHARACTERIZATION
- CELL AND TISSUE ANALYSIS
- RESEARCH AND ACADEMICS
- BIOPHARMACEUTICALS
- HEALTHCARE AND CLINICAL
Chapter- 7: CELL AND TISSUE SEPARATION PRODUCT MARKET ANALYSIS
- MARKET BY TYPES
- MARKET BY REGION
- MARKET BY END USERS
- RESEARCH AND ACADEMIC
- BIOPHARMACEUTICALS
- HEALTHCARE AND CLINICAL
Chapter- 8: PATENT ANALYSIS
- PATENTS BY YEAR
- PATENTS BY CATEGORY
- PATENTS BY COMPANY
- PATENTS BY COUNTRY
- PATENTS BY ASSIGNEE
Chapter- 9: CURRENT SITUATION
- CELL AND TISSUE ANALYSIS TECHNIQUES AS DIAGNOSTIC TOOLS
- FUTURE PERSPECTIVE
Chapter- 10: COMPANY PROFILES
- ABCAM, PLC.
- ABNOVA
- ACCURI CYTOMETERS INC.
- AFFYMETRIX
- ANALYTICAL BIOLOGICAL SERVICES INC.
- ARRAYIT CORPORATION
- BD BIOSCIENCES
- BECKMAN COULTER INC.
- CARL ZEISS MICROIMAGING GMBH
- CLONTECH LABORATORIES
- CYBRDI INC.
- EBIOSCIENCE INC.
- EUROGENTEC S.A.
- GE HEALTHCARE
- ILLUMINA INC.
- INVITROGEN CORPORATION
- LC SCIENCES
- LEICA MICROSYSTMS
- MDS ANALYTICAL TECHNOLOGIES
- MEDIX BIOCHEMICA
- MERCK SERONO SA
- MILTENYI BIOTEC
- MILLIPORE
- PARTEC GMBH
- PERKIN ELMER INC.
- ROCHE APPLIED SCIENCE
- SIGMA-ALDRICH INC.
- SOUTHERN BIOTECH
- STEM CELL TECHNOLOGIES
- STRATIGIC DIAGNOSTICS
- TGA SCIENCES
- THERMO FISHER SCIENTIFIC
- WORTHINGTON BIOCHEMICAL CORPORATION
Chapter- 11: APPENDIX: ABBREVIATIONS
List of Tables
- Summary Table : GLOBAL CELL AND TISSUE ANALYSIS MARKET BY PRODUCT TYPE,
THROUGH 2017
- Table 1 : DIFFERENCES BETWEEN PROKARYOTIC CELLS AND EUKARYOTIC CELLS
- Table 2 : PLANT AND ANIMAL CELL DIFFERENCES
- Table 3 : TISSUE TYPES
- Table 4 : CELL AND TISSUE ANALYSIS CLASSIFICATION TECHNIQUES
- Table 5 : FDA-APPROVED CELL AND TISSUE ANALYSIS PRODUCTS, 2010 - MAY 2012
- Table 6 : FDA PRODUCT RECALLS FOR CELL AND TISSUE ANALYSIS PRODUCTS, 2012
- Table 7 : FDA PRODUCT RECALLS FOR CELL AND TISSUE ANALYSIS PRODUCTS, 2011
- Table 8 : FDA PRODUCT RECALLS FOR CELL AND TISSUE ANALYSIS PRODUCTS, 2010
- Table 9 : FDA PRODUCT RECALLS FOR CELL AND TISSUE ANALYSIS PRODUCTS, 2009
- Table 10 : CELL AND TISSUE ANALYSIS PRODUCTS IN THE PIPELINE
- Table 11 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2012
- Table 12 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2011
- Table 13 : NEW DEVELOPMENTS AND ADVANCEMENTS, 2010
- Table 14 : GLOBAL CELL AND TISSUE ANALYSIS PRODUCT MARKET BY TYPE, THROUGH
2017
- Table 15 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY TYPE, 2011
- Table 16 : GLOBAL BIOSPECIMEN-PREPARING TECHNIQUE PRODUCT MARKET BY TYPE,
THROUGH 2017
- Table 17 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE, THROUGH 2017
- Table 18 : CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET BY TYPE,
THROUGH 2017
- Table 19 : CELL AND TISSUE ANALYSIS PRODUCT MARKET BY REGION, THROUGH 2017
- Table 20 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY REGION, 2011
- Table 21 : GLOBAL BIOSPECIMEN-PREPARING TECHNIQUE MARKET BY REGION,
THROUGH 2017
- Table 22 : BIOSPECIMEN-PREPARING TECHNIQUE PRODUCTS MARKET SHARE BY
REGION, 2011
- Table 23 : GLOBAL CELL AND TISSUE SEPARATION PRODUCT MARKET BY REGION,
THROUGH 2017
- Table 24 : CELL AND TISSUE SEPARATION PRODUCT MARKET SHARE BY REGION, 2010
- Table 25 : GLOBAL CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET BY
REGION, THROUGH 2017
- Table 26 : GLOBAL CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET SHARE BY
REGION, 2011
- Table 27 : GLOBAL CELL AND TISSUE ANALYSIS PRODUCT MARKET BY END USER,
THROUGH 2017
- Table 28 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY END USER, 2011
- Table 29 : CELL AND TISSUE ANALYSIS PRODUCT CONSUMPTION IN RESEARCH AND
ACADEMICS BY REGION, THROUGH 2017
- Table 30 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN RESEARCH AND
ACADEMICS BY REGION, 2011
- Table 31 : CELL AND TISSUE ANALYSIS PRODUCT CONSUMPTION IN
BIOPHARMACEUTICALS BY REGION, THROUGH 2017
- Table 32 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN
BIOPHARMACEUTICALS BY REGION, 2011
- Table 33 : CELL AND TISSUE ANALYSIS PRODUCT CONSUMPTION IN THE HEALTHCARE
AND CLINICAL INDUSTRY BY REGION, THROUGH 2017
- Table 34 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN THE HEALTHCARE
AND CLINICAL INDUSTRY BY REGION, 2011
- Table 35 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE, THROUGH 2017
- Table 36 : ENZYMATIC DISSOCIATOR PRODUCT MARKET BY REGION, THROUGH 2017
- Table 37 : MAGNETIC SEPARATOR PRODUCT MARKET BY REGION, THROUGH 2017
- Table 38 : LASER MICRODISSECTION PRODUCT MARKET BY REGION, THROUGH 2017
- Table 39 : FLOW CYTOMETER PRODUCT MARKET BY REGION, THROUGH 2017
- Table 40 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY REGION, THROUGH
2017
- Table 41 : NORTH AMERICAN CELL AND TISSUE SEPARATION PRODUCT MARKET BY
TYPE, THROUGH 2017
- Table 42 : EUROPEAN CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE,
THROUGH 2017
- Table 43 : EMERGING MARKETS CELL AND TISSUE SEPARATION PRODUCT MARKET BY
TYPE, THROUGH 2017
- Table 44 : CELL AND TISSUE SEPARATION MARKET BY END - USER, THROUGH 2017
- Table 45 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN RESEARCH AND
ACADEMICS BY REGION, THROUGH 2017
- Table 46 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN
BIOPHARMACEUTICALS BY REGION, THROUGH 2017
- Table 47 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN THE
HEALTHCARE AND CLINICAL INDUSTRY BY REGION, THROUGH 2017
- Table 48 : CELL AND TISSUE SEPARATION PRODUCT MARKET LEADERS
- Table 49 : MANUFACTURERS AND DISTRIBUTORS OF TISSUE SEPARATION PRODUCTS BY
MARKET SHARE, 2011
- Table 50 : ENZYMATIC DISSOCIATOR MARKET LEADERS
- Table 51 : ENZYMATIC DISSOCIATOR MANUFACTURERS AND DISTRIBUTORS BY MARKET
SHARE, 2011
- Table 52 : MAGNETIC SEPARATOR MARKET LEADERS
- Table 53 : MAGNETIC SEPARATION PRODUCT MANUFACTURERS AND DISTRIBUTORS BY
MARKET SHARE, 2011
- Table 54 : LASER-MICRODISSECTION PRODUCT MARKET LEADERS
- Table 55 : LASER-MICRODISSECTION PRODUCT MANUFACTURERS AND DISTRIBUTORS BY
MARKET SHARE, 2011
- Table 56 : FLOW-CYTOMETER PRODUCT MARKET LEADERS
- Table 57 : FLOW-CYTOMETER PRODUCT MANUFACTURERS AND DISTRIBUTORS BY MARKET
SHARE, 2011
- Table 58 : CELL AND TISSUE ANALYSIS, 2008-2012
- Table 59 : CELL AND TISSUE ANALYSIS PRODUCT PATENTS BY TYPE, 2008 - 2012
- Table 60 : U.S. PATENTS FOR CELL AND TISSUE ANALYSIS PRODUCTS BY COMPANY,
2008 - 2012
- Table 61 : U.S. PATENTS FOR CELL AND TISSUE ANALYSIS PRODUCTS BY COUNTRY,
2008 - 2012
- Table 62 : CELL AND TISSUE ANALYSIS PRODUCT PATENT SHARES BY COUNTRY, 2010
- 2011
- Table 63 : CELL AND TISSUE ANALYSIS PRODUCT PATENTS BY ASSIGNEE TYPE, 2008
- 2012
- Table 64 : CELL AND TISSUE ANALYSIS PRODUCT PATENT SHARES BY ASSIGNEE
TYPE, 2010 - 2011
List of Figures
- Summary Figure : GLOBAL CELL AND TISSUE ANALYSIS MARKET BY PRODUCT TYPE,
2010-2017
- Figure 1 : SCHEMATIC REPRESENTATION OF A FLOW CYTOMETER
- Figure 2 : SCHEMATIC REPRESENTATION OF THE QUADRUPOLE MAGNETIC SORTER
- Figure 3 : GLOBAL CELL AND TISSUE ANALYSIS PRODUCT MARKET BY TYPE,
2010-2017
- Figure 4 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY TYPE, 2011
- Figure 5 : GLOBAL BIOSPECIMEN-PREPARING TECHNIQUE PRODUCT MARKET BY TYPE,
2010-2017
- Figure 6 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE, 2010-2017
- Figure 7 : CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET BY TYPE,
2010-2017
- Figure 8 : CELL AND TISSUE ANALYSIS PRODUCT MARKET BY REGION, 2010-2017
- Figure 9 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY REGION, 2011
- Figure 10 : GLOBAL BIOSPECIMEN-PREPARING TECHNIQUE PRODUCTS MARKET BY
REGION, 2010-2017
- Figure 11 : BIOSPECIMEN-PREPARING TECHNIQUE PRODUCT MARKET SHARE BY
REGION, 2011
- Figure 12 : GLOBAL CELL AND TISSUE SEPARATION PRODUCT MARKET BY REGION,
2010-2017
- Figure 13 : CELL AND TISSUE SEPARATION PRODUCT MARKET SHARE BY REGION, 2010
- Figure 14 : GLOBAL CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET BY
REGION, THROUGH 2017
- Figure 15 : GLOBAL CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET SHARE
BY REGION, 2011
- Figure 16 : GLOBAL CELL AND TISSUE CHARACTERIZATION PRODUCT MARKET BY END
USER, 2010-2017
- Figure 17 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE BY END USER, 2011
- Figure 18 : CELL AND TISSUE ANALYSIS PRODUCTION CONSUMPTION IN RESEARCH
AND ACADEMICS BY REGION, 2010-2017
- Figure 19 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN RESEARCH AND
ACADEMICS BY REGION, 2011
- Figure 20 : CELL AND TISSUE ANALYSIS PRODUCT CONSUMPTION IN
BIOPHARMACEUTICALS BY REGION, 2010-2017
- Figure 21 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN
BIOPHARMACEUTICALS BY REGION, 2011
- Figure 22 : CELL AND TISSUE ANALYSIS PRODUCT CONSUMPTION IN THE HEALTHCARE
AND CLINICAL INDUSTRY BY REGION, 2010-2017
- Figure 23 : CELL AND TISSUE ANALYSIS PRODUCT MARKET SHARE IN THE
HEALTHCARE AND CLINICAL INDUSTRY BY REGION, 2011
- Figure 24 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE, 2010-2017
- Figure 25 : ENZYMATIC DISSOCIATOR PRODUCT MARKET BY REGION, 2010- 2017
- Figure 26 : MAGNETIC SEPARATOR PRODUCT MARKET BY REGION, 2010-2017
- Figure 27 : LASER MICRODISSECTION PRODUCT MARKET BY REGION, 2010-2017
- Figure 28 : FLOW CYTOMETER PRODUCT MARKET BY REGION, 2010-2017
- Figure 29 : CELL AND TISSUE SEPARATION PRODUCT MARKET BY REGION, 2010-2017
- Figure 30 : NORTH AMERICAN CELL AND TISSUE SEPARATION PRODUCT MARKET BY
TYPE, 2010-2017
- Figure 31 : EUROPEAN CELL AND TISSUE SEPARATION PRODUCT MARKET BY TYPE,
2010-2017
- Figure 32 : EMERGING MARKETS CELL AND TISSUE SEPARATION PRODUCT MARKET BY
TYPE, 2010-2017
- Figure 33 : CELL AND TISSUE SEPARATION MARKET BY END - USER, 2010-2017
- Figure 34 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN RESEARCH AND
ACADEMICS BY REGION, 2010-2017
- Figure 35 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN
BIOPHARMACEUTICALS BY REGION, 2010-2017
- Figure 36 : CELL AND TISSUE SEPARATION PRODUCT CONSUMPTION IN THE
HEALTHCARE AND CLINICAL INDUSTRY BY REGION, 2010-2017
- Figure 37 : MANUFACTURERS AND DISTRIBUTORS OF TISSUE SEPARATION PRODUCTS
BY MARKET SHARE, 2011
- Figure 38 : ENZYMATIC DISSOCIATOR MANUFACTURERS AND DISTRIBUTORS BY MARKET
SHARE, 2011
- Figure 39 : MAGNETIC SEPARATION PRODUCT MANUFACTURERS AND DISTRIBUTORS BY
MARKET SHARE, 2011
- Figure 40 : LASER-MICRODISSECTION PRODUCT MANUFACTURERS AND DISTRIBUTORS
BY MARKET SHARE, 2011
- Figure 41 : FLOW-CYTOMETER PRODUCT MANUFACTURERS AND DISTRIBUTORS BY
MARKET SHARE, 2011
- Figure 42 : CELL AND TISSUE ANALYSIS, 2008-2012
- Figure 43 : CELL AND TISSUE ANALYSIS PRODUCT PATENTS BY YEAR, 2008-2012
- Figure 44 : CELL AND TISSUE ANALYSIS PRODUCT PATENTS BY TYPE, 2008-2012
- Figure 45 : U.S. PATENTS FOR CELL AND TISSUE ANALYSIS PRODUCTS BY COUNTRY,
2008-2012
- Figure 46 : CELL AND TISSUE ANALYSIS PRODUCT PATENT SHARES BY COUNTRY,
2010-2011
- Figure 47 : CELL AND TISSUE ANALYSIS PRODUCT PATENTS BY ASSIGNEE TYPE,
2008-2012
- Figure 48 : CELL AND TISSUE ANALYSIS PRODUCT PATENT SHARES BY ASSIGNEE
TYPE, 2010-2011
